Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The quinone binding site of the cytochrome bc1 complex (Complex III) in Neisseria gonorrhoeae is a critical component of the bacterial respiratory chain, facilitating the transfer of electrons from ubiquinol to cytochrome c. This process, known as the Q-cycle, involves two distinct catalytic sites: the quinol oxidation (Qo) site and the quinone reduction (Qi) site, both located within the cytochrome b subunit. In N. gonorrhoeae, this complex is essential for maintaining the proton motive force required for ATP synthesis and supporting growth under the microaerobic and anaerobic conditions encountered during infection. Recent research has identified the Qo site as a highly selective therapeutic target for treating multidrug-resistant gonorrhea. Small molecules such as 2-nonyl-4-quinolone N-oxide (NQNO) and its derivatives competitively inhibit this site, leading to rapid ATP depletion and the activation of endogenous toxin-antitoxin systems, such as the Zeta1 toxin, which results in bacterial cell death. Importantly, these inhibitors can demonstrate high selectivity for the gonococcal enzyme over human mitochondrial counterparts, offering a path for narrow-spectrum antibiotic development.
Inhibition of electron transfer by competitively blocking the quinol oxidation (Qo) site of the cytochrome bc1 complex, which disrupts the Q-cycle, halts the respiratory chain, and induces lethal oxidative stress and toxin release.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Quinone binding site of the cytochrome bc1 complex (Qo site).